##common.search##
##search.searchResults##
-
MEASURES TO PREVENT RECURRENCE AFTER SURGICAL TREATMENT OF LIVER ECHINOCOCCOSIS
The clinical study included 371 patients with liver echinococcosis. Optimization of the tactics of surgical treatment of liver echinococcosis, taking into account the choice of access, method of treatment and elimination of the residual cavity, as well as correction of the course of prophylactic chemotherapy, improved the quality of care by reducing the frequency of immediate postoperative complications from 12.5% to 4.3% and the recurrence of the disease from 11.9% to 2.6%. It is clinically justified to correct the dose of albendazole for the prevention of recurrence of liver echinococcosis in patients with concomitant chronic diffuse liver pathology, which made it possible to reduce the likelihood of adverse reactions from 52.7% to 18.3%, and, accordingly, indicators of hepatic aminotransferases: ALT in the comparison group from 1.14± 0.11 to 0.62±0.05 mmol/l in the main group and AST from 0.72±0.07 to 0.52±0.04 mmol/l.
-
SURGERY AND CHEMOTHERAPY OF COMPLICATED FORM OF LIVER ECHINOCOCCOSIS
The results of treatment of 328 (51.4%) patients with liver echinococcosis are presented. The use of the ultrasonic dissector of the SONOCA 300 aspirator makes it possible to make wider use of radical modern methods of surgical interventions for echinococcosis, to perform them bloodlessly, with good final aero-, hemo- and cholestasis with minimal tissue trauma in the affected area. The developed algorithms for choosing tactics for surgical treatment of echinococcosis, taking into account an integrated approach to the choice of access, mainly to radical echinococcectomy and elimination of the residual cavity, as well as preventive chemotherapy, made it possible to improve the quality of care provided by reducing the frequency of immediate postoperative complications from 14.3% to 3.7 % (p=0.027 by χ2 criterion) and disease relapse from 13.4% to 2.8% (p=0.031 by χ2 criterion).